ci 943 has been researched along with dextroamphetamine in 1 studies
| Studies (ci 943) | Trials (ci 943) | Recent Studies (post-2010) (ci 943) | Studies (dextroamphetamine) | Trials (dextroamphetamine) | Recent Studies (post-2010) (dextroamphetamine) |
|---|---|---|---|---|---|
| 9 | 0 | 1 | 7,044 | 697 | 660 |
| Protein | Taxonomy | ci 943 (IC50) | dextroamphetamine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.631 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.2884 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Downs, DA; Heffner, TG; Meltzer, LT; Wiley, JN; Williams, AE | 1 |
1 other study(ies) available for ci 943 and dextroamphetamine
| Article | Year |
|---|---|
CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Cebus; Dextroamphetamine; Dopamine Antagonists; Imidazoles; Male; Mice; Motor Activity; Pyrimidines; Rats; Rats, Inbred Strains; Saimiri; Stereotyped Behavior | 1989 |